市場調査レポート

商品コード

1463483

妊活サプリメントの世界市場規模、シェア、成長分析、最終用途別、流通チャネル別 - 産業予測、2024～2031年

Global Fertility Supplements Market Size, Share, Growth Analysis, By End-Use(Men, and Women), By Distribution Channel(OTC, and Prescribed) - Industry Forecast 2024-2031

出版日: 2024年04月11日 | 発行: SkyQuest

| ページ情報: 英文 198 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 834,909円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 976,686円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,118,463円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.53円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の妊活サプリメントの市場規模は、2022年に19億4,000万米ドルとなり、2023年の21億米ドルから、2031年までには38億8,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは8％で成長する見通しです。

不妊治療薬産業は、人々に生殖機能を強化し、妊娠の可能性を高める別の方法を提供するために存在します。妊活サプリメント市場を推進している主要な要因の一つは、不妊症の発生率の上昇です。生殖機能を強化するために栄養補助食品を使用することの利点に関する消費者の知識が広まるとともに、これらのサプリメントが店頭で入手しやすくなった結果、市場は拡大しています。妊活サプリメント市場を阻害している主要な障害のひとつは、規制当局の監督下にないことと、製品の品質にばらつきがあることです。加えて、一部のサプリメントは高価であるため、利用できない人もいます。これらのサプリメントが生殖能力を高める能力を実証する科学的証拠がないことは、妊活サプリメント市場が直面する大きな障害のひとつです。さらに、不妊症につきまとう汚名や、治療を受けたがらない人々がいることも、市場の成長に影響を与える可能性があります。eコマース・プラットフォームの利用が拡大し、より多様な妊活サプリメントが入手可能になれば、新たな市場展望が生まれると予想されます。さらに、カスタマイズされた栄養の人気の高まりや、斬新な商品や処方の創出は、市場の拡大を促進する可能性があります。今後数年間は、生殖機能を高めるために従来とは異なる方法を求める人が増えるため、妊活サプリメントの世界市場はさらに拡大すると予想されます。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要な投資の分析
主要な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

妊活サプリメントの世界市場：最終用途別

市場概要
男性
女性

妊活サプリメントの世界市場：流通チャネル別

市場概要
店頭
処方箋

妊活サプリメントの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

TTK HealthCare（India）
Fairhaven Health LLC（U.S.）
Zenith Nutritions（India）
INVO Bioscience（U.S.）
Vitabiotics Ltd（U.K.）
Bionova Lifesciences（India）
Exeltis USA Inc.（U.S.）
Fujifilm Irvine Scientific, Inc.（U.S.）
Coast Science（U.S.）
Orthomol（Germany）
Theralogix LLC（U.S.）
Mira（U.S.）
Proxeed Plus（U.S.）
Fertility Nutraceuticals LLC（U.S.）
Fertility Focus Limited（U.K.）
DCC plc（Ireland）
Purelife Bioscience Co. Ltd.（Taiwan）
Fertility Smart（Australia）
Concepta Diagnostics（U.K.）
TTK Prestige Ltd（India）

Product Code: SQMIG30I2247

Global Fertility Supplements Market size was valued at USD 1.94 billion in 2022 and is poised to grow from USD 2.10 billion in 2023 to USD 3.88 billion by 2031, growing at a CAGR of 8% during the forecast period (2024-2031).

The industry for fertility pills exists to give people a different way to enhance their reproductive health and boost their chances of getting pregnant. One of the main factors propelling the fertility supplement market is the rising incidence of infertility. The market is expanding as a result of growing consumer knowledge of the advantages of using dietary supplements to enhance reproductive health as well as the accessibility of these supplements over-the-counter. One major obstacle impeding the fertility supplement market is the absence of regulatory supervision and uneven product quality. In addition, some people may not be able to access some supplements due to their high cost. The absence of scientific proof demonstrating these supplements' ability to increase fertility is one of the major obstacles facing the market for fertility supplements. Furthermore, the stigma attached to infertility and some people's unwillingness to seek treatment could have an effect on the market's growth. It is anticipated that new market prospects would arise from the growing use of e-commerce platforms and the availability of a greater variety of fertility supplements. Furthermore, the growing popularity of customized nutrition and the creation of novel goods and formulas could propel market expansion. In the upcoming years, it is anticipated that the global market for fertility supplements would expand further as more people look for non-traditional ways to enhance their reproductive health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility Supplements Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fertility Supplements Market Segmental Analysis

The global fertility supplements market is segmented on the basis of product, application, and region. By end-use, the market is bifurcated into men, and women. In terms of distribution channel, the market is segmented into OTC, and prescribed. By region, the market is widespread into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Fertility Supplements Market

The market for fertility supplements is mostly driven by the increased incidence of infertility in both men and women. The CDC reports that infertility affects approximately 15% of couples worldwide, and the number is rising. Because they provide a safe and affordable substitute for traditional fertility therapies, this has resulted in an increase in demand for fertility supplements.

Restraints in the Global Fertility Supplements Market

Despite the growing acceptance of fertility supplements, there is insufficient scientific data to substantiate their efficacy. Many of the manufacturer's claims are not supported by thorough clinical trials or studies, which has caused some customers and healthcare experts to be skeptical.

Market Trends of the Global Fertility Supplements Market

Consumers are increasingly opting for natural and organic fertility supplements as they are perceived to be safer and have fewer side effects. These supplements are made from natural ingredients such as herbs, vitamins, and minerals, and do not contain any synthetic substances. For instance, In folic, a natural supplement made from myo-inositol and folic acid, has gained popularity in the market due to its natural composition and effectiveness in promoting fertility.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Fertility Supplements Market by End-Use

Market Overview
Men
and Women

Global Fertility Supplements Market by Distribution Channel

Market Overview
OTC
and Prescribed

Global Fertility Supplements Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

TTK HealthCare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fairhaven Health LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zenith Nutritions (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
INVO Bioscience (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitabiotics Ltd (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionova Lifesciences (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exeltis USA Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Irvine Scientific, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coast Science (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthomol (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Theralogix LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mira (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proxeed Plus (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertility Nutraceuticals LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertility Focus Limited (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DCC plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Purelife Bioscience Co. Ltd. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertility Smart (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Concepta Diagnostics (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK Prestige Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments